UBS ASSET MANAGEMENT AMERICAS LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 144 filers reported holding THERAPEUTICSMD INC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2021$268,228,000
-37.7%
361,7860.0%0.00%
Q2 2021$430,526,000
+36.0%
361,786
+53.2%
0.00%
Q1 2021$316,522,000
+120.6%
236,210
+99.2%
0.00%
Q4 2020$143,452,000
-50.4%
118,555
-35.2%
0.00%
Q3 2020$289,205,000
-0.3%
183,041
-21.1%
0.00%
Q2 2020$290,043,000
+50.7%
232,034
+27.8%
0.00%
Q1 2020$192,460,000
-61.4%
181,566
-11.8%
0.00%
Q4 2019$498,236,000
-33.0%
205,883
+0.4%
0.00%
-100.0%
Q3 2019$744,121,000
+98.8%
204,992
+42.4%
0.00%
Q2 2019$374,224,000
-36.2%
143,932
+19.6%
0.00%
Q1 2019$586,313,000
+39.3%
120,393
+9.0%
0.00%
Q4 2018$420,753,000
-43.4%
110,434
-2.5%
0.00%
-100.0%
Q3 2018$743,071,000
+6.7%
113,273
+1.5%
0.00%0.0%
Q2 2018$696,509,000
+28.8%
111,620
+0.5%
0.00%
Q1 2018$540,833,000
-8.9%
111,054
+13.0%
0.00%
-100.0%
Q4 2017$593,509,000
+19.4%
98,263
+4.6%
0.00%
Q3 2017$497,064,000
+12.3%
93,963
+11.9%
0.00%
Q2 2017$442,596,000
-27.9%
83,984
-1.5%
0.00%
-100.0%
Q1 2017$613,591,000
+142595.6%
85,221
+14.4%
0.00%
Q4 2016$430,000
-42.5%
74,472
-32.2%
0.00%
-100.0%
Q3 2016$748,000
-17.1%
109,772
+3.6%
0.00%0.0%
Q2 2016$902,000
+59.1%
105,954
+19.4%
0.00%0.0%
Q1 2016$567,000
-44.6%
88,717
-10.1%
0.00%0.0%
Q4 2015$1,024,000
+143.8%
98,739
+37.7%
0.00%
Q3 2015$420,000
+12.0%
71,700
+50.3%
0.00%
Q2 2015$375,00047,7000.00%
Other shareholders

There were no reported owners of THERAPEUTICSMD INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of THERAPEUTICSMD INC shareholders